moxifloxacin has been researched along with topiroxostat in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (topiroxostat) | Trials (topiroxostat) | Recent Studies (post-2010) (topiroxostat) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 80 | 17 | 69 |
| Protein | Taxonomy | moxifloxacin (IC50) | topiroxostat (IC50) |
|---|---|---|---|
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 0.8919 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Hashimoto, H; Kumagai, Y; Nakamura, Y; Sugiyama, A | 1 |
1 trial(s) available for moxifloxacin and topiroxostat
| Article | Year |
|---|---|
QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation.
Topics: Adult; Asian People; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Nitriles; Pyridines; Xanthine Oxidase; Young Adult | 2014 |